ER-100 FDA Clearance | First Epigenetic Reprogramming Human

ER-100 receives FDA IND clearance January 28, 2026, the first human trial of partial epigenetic reprogramming using AAV2-delivered OSK Yamanaka factors

William Rodriguez

|July 11, 2026|4 min read

Article content for: ER-100 FDA Clearance | First Epigenetic Reprogramming Human

Discussion

Comments post live to the OzoneNews Discord server.

Join server →

Every comment appears live in our Discord server.

Join to see the full conversation and connect with the community.

Join OzoneNews Discord

Comments sync to our OzoneNews Discord · ER-100 FDA Clearance | First Epigenetic Reprogramming Human.

Written by

William Rodriguez

ER-100 FDA Clearance | First Epigenetic Reprogramming Human

More from Microsoft

ESA Confirms Corrosion on NASA's Cancelled Lunar Gateway HALO and I-HAB Modules

Rockefeller CRISPR Study Turns Stem Cells Into Living Drug Factories

Oslo Patient Becomes Roughly the Tenth Person Cured of HIV | CCR5 Mutation, Bone Marrow Transplant

Vast Freshwater Reservoir Found Beneath the Great Salt Lake

Artemis II Blasts Off on Historic 10-Day Lunar Journey

First Close Pair of Supermassive Black Holes Detected Nearing Merger

Discussion